OpenSAFELY is open from today! Huge thanks to all who supported this vast collaboration: whole population GP data; in a productive platform; innovative privacy protections; unprecedented support from professions, privacy campaigners; &c
Now it's over to users!
www.bennett.ox.ac.uk/blog/2026/02...
www.deadlanguagesociety.com/p/how-far-ba...
I cannot speak as to the accuracy of the piece yet I found it a fascinating exercise @adamroberts.bsky.social @drlauravarnam.bsky.social
👉...cutting-edge science, clinical insights & discussions re: real-world implementation of TIL therapy.
Featuring keynote speakers:
Inge Marie Svane 🇩🇰 & Sebastian Klobuch 🇳🇱.
@sklobuch.bsky.social
@debrajosephs.bsky.social
@turajliclab.bsky.social
@beckilee.bsky.social
lab to life
Exciting conference alert!
sites.manchester.ac.uk/from-lab-to-...
Fantastic speakers including Chris Marine, Christian Blank
Melanoma evolution
Local microenvironment of melanoma
Melanoma-host interactions
Precision immunotherapy
Emerging therapeutics
Clinical trials and real-world data
🩺 Fantastic opportunity for #YoungOncologists: ICF-ESMO programme for an 8-week observership.
We've excellent opportunities here in Manchester & would be happy to support (✉️: the-christie.observers@nhs.net).
@christieinstitute.bsky.social
@myesmo.bsky.social
📥 For more info (due 25 Jan 2026) 👇
Excited about not one but 2 fantastic conferences in Manchester! So timely as cell therapies are on the standard care horizon!
⏰ Calling all melanoma enthusiasts!
The abstract submission deadline for the inaugural “Lab to Life: Innovations in Melanoma Research Conference UK 2026” has been extended to 19 December 2025!
Happening 12-13 March 2026 at The Midland Hotel, Manchester.
Submit your abstract and register here:
Cat watching cancer detectives
Cancer detectives a hit in our house!
Bench to bedside look at the DETECTION trial- Inspiring scientists of the future and an insight into why science is important, the breakthroughs they fund and what it means to the people involved
www.channel4.com/programmes/c...
Cat
Cat
Happy Halloween from these two!
Lab group
Melanoma UK today visited the Smiths Melanoma hub today learning about the amazing work all of these lovely people are doing! Thanks for funding us! @mcrcnews.bsky.social
Attending #ESMO25
Join us to learn about sustainability integration into cancer care and the environmental impacts of AI 👇
@myesmo.bsky.social @robchuter.bsky.social @beckilee.bsky.social @pawelsobczuk.bsky.social @ouchinternational.bsky.social @irishdocsenv.bsky.social @cancertrialsie.bsky.social
Amazing work throughout the UK to smash our recruitment target!
Screenshot of the front page of the carers in STEMM survey report
We are pleased to announce the publication of our STEMM sector-wide survey
The report highlights our findings & suggests recommendations. Now available to download here carersinstemm.co.uk
Please share especially w/ institutions, funders & allies
@laurawolz.bsky.social @carterlj.bsky.social
NEW: Nature trained AI to predict which NIH grants from 2014 would have been cut if the Trump admin had its way back then — and what science would have been lost to history.
"The results show the damage that cuts in funding can do to research, and the unpredictable nature of the research process."
For our #flowcytometry peeps, would you like to have a single fix/perm protocol that is optimised for everything? One that preserves fluorophores while allowing simultaneous TF and cytokine staining? How about 100-fold cheaper?
You got it:
currentprotocols.onlinelibrary.wiley.com/doi/10.1002/...
Very pleased to say DETECTION2 has just randomised it's 50th patient! Awesome work by patient groups @melanomafocus.bsky.social , UK clinical teams @christieinstitute.bsky.social R+I and SCTU funded by @cancerresearchuk.org
v1.108 is rolling out today 🚚
Now live, at long last: Bookmarks, aka Saved Posts. For all those posts you'll definitely plan to come back to!
Update the app and give it a try. The button is right down there 👇
The Lee lab is expanding! We are really interested in mechanisms of local and systemic immune tolerance particularly in liver metastases - X2 research technicians
💡 Creative fun environment
🌱 Opportunities to grow
🫂 Highly collaborative with clinical+basic research
📢 Please spread word!
Calling all ECRs in cancer and metastasis research. Don't forget to register for the upcoming ECR Virtual Symposium in November (FREE for MRS members). More details here metastasis-research.org/2025/08/06/2...
⭐We have a clinical fellow opportunity with the melanoma team! ⭐
Very friendly and supportive team
Lots of learning opportunities including clinical trials and immune therapy
Apply here👇
urldefense.com/v3/__https:/...
🚨 Exciting new paper alert 🚨 From the Marie lab
⭐They have identified new melanoblast cell states which are reawakened in metastasizing and immunotherapy resistant melanoma
⭐ Can target using hdac inhibitors
#melsm #melanoma #cancer
www.biorxiv.org/content/10.1...
I’m happy to share our latest work on tumour necrosis! During my time in the @megeblad.bsky.social lab, we found that tumour necrosis is not a passive phenomenon secondary to tumour growth, but an active phenomenon driven by neutrophils and NETs! Thread below: (1/13)
www.nature.com/articles/s41...
Congratulations 🎉
Congratulations! 🎉
Congratulations!
Mathematical models and ctdna have reached the clinic - the ultimate personalised trial testing adaptive targeted therapy highlighted in the news today!
#EBEcancer25
www.express.co.uk/life-style/h...
Absolutely loving this course - fantastic discussions between all and the delegates and faculty. So many exciting Q's coming out of this!
Excited to share our new study on how resistance to AKT inhibition is linked to lineage differences within breast cancer 👇🏽 Stellar work @colindhratcliffe.bsky.social www.biorxiv.org/content/10.1...
and also surprisingly/worryingly good AI generated podcast 🎧 notebooklm.google.com/notebook/28e...
Congratulations! Looking forward to seeing the data
